Rx Rundown: The FTC, Moderna, Publicis Health and more
Check out this week’s medical marketing news, people on the move and industry chatter.
Stay updated with breaking news from Tilde Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Check out this week’s medical marketing news, people on the move and industry chatter.
BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global healthcare and specialty pharmacy (SP) solutions company, announces that Tilde Sciences, specializing in the development and commercialization of specialty pharmaceuticals, has chosen AscellaHealth’s Specialty Pharmacy, Optime Care as its exclusive distribution,...
/PRNewswire/ -- Tilde Sciences, a specialty pharmaceutical company, announced today that it has acquired two medicines, Daraprim® and Vecamyl® from Vyera...
As part of Vyera Pharmaceuticals’ bankruptcy, it will sell off Daraprim and hypertension drug Vecamyl to Tilde Sciences for $650,000.